GlycanAge
The company provides a biological age testing service that measures glycan biomarkers on antibodies to assess immune system health and chronic inflammation. Customers use a home finger-prick blood kit to receive a personalized report and a consultation with a longevity specialist to interpret results. The service targets individuals interested in longevity, healthcare providers integrating biological age tracking into clinical practice, and researchers conducting glycobiology studies.
Visit websiteNewcastle upon Tyne, UK
Healthtech
Biotechnology
Diagnostics
Longevity
Funding summary
- Total raised
- €11.3M
- Funding rounds
- 2
Investors in GlycanAge
Investors on record for GlycanAge. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like GlycanAge?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors